Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, AbCellera (ABCL) has a market cap of $0.72 billion USD. According to our data, AbCellera is ranked No.5480 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.72 B |
-16.33%
|
| Dec 31, 2024 | $0.87 B |
-48.69%
|
| Dec 29, 2023 | $1.69 B |
-43.63%
|
| Dec 30, 2022 | $2.99 B |
-29.16%
|
| Dec 31, 2021 | $4.22 B |
-64.46%
|
| Dec 31, 2020 | $11.89 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
| Market Cap | = | ABCL Stock Price | * | ABCL Shares Outstanding |
| = | $2.43 | * | 0.30 B | |
| = | $0.72 B |